Reborna Biosciences

About:

Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.

Website: https://rebornabiosciences.com/

Top Investors: Takeda, Mitsubishi UFJ Capital

Description:

Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients suffering from rare genetic diseases including spinal muscular atrophy.